Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance
建立和维持肺同种异体移植耐受的炎症细胞机制
基本信息
- 批准号:10197018
- 负责人:
- 金额:$ 47.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-12 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAllograft ToleranceAnimalsAntigen-Presenting CellsAntigensAutologousBispecific AntibodiesCD8-Positive T-LymphocytesCellsChronicClinicalComplementDataDendritic CellsDevelopmentDown-RegulationFOXP3 geneFamilyFeedbackFoundationsFundingGTP-Binding Protein alpha Subunits, GsGraft RejectionGraft SurvivalGraft ToleranceGrantHealthHematopoieticHumanImmune responseImmunosuppressionInflammation MediatorsInflammatoryInterferon Type IIInterferonsInterleukin-1Interleukin-1 betaLungLung TransplantationLymphoidMaintenanceMediatingMethodsNOS2A geneNitric OxideNitric Oxide SynthaseOrganOrgan TransplantationPD-1/PD-L1Pathway interactionsPlayPopulationPost-Translational Protein ProcessingProductionProtocols documentationRegulatory T-LymphocyteRoleShapesSignal TransductionSolidSpecificitySurfaceT cell differentiationT-Cell ReceptorT-LymphocyteTNF geneTestingTransplantation ToleranceWorkallograft rejectionbasechemokinecytokineeosinophilexperienceimmunoregulationimprovedin vivointerstitiallung allograftlung developmentmacrophagemembermigrationmonocytemouse modelnovelpreventprogrammed cell death ligand 1receptorresponsesynaptogenesis
项目摘要
PROJECT SUMMARY/ABSTRACT
Studies utilizing the murine model of lung transplantation have helped advance our understanding
of lung allograft-specific immunoregulation. Unlike other solid organs, the lung relies on pro-
inflammatory feedback loops for establishing and maintaining graft acceptance. We have
described that CD8+ T cells, long considered deleterious to solid organ allograft survival, play a
critical role in lung allograft tolerance. During the last funding period we have uncovered that
lung-resident eosinophils, also considered a detrimental cell population for graft health, shape
CD8+ T cell fate to prevent their effector differentiation. We have also described that such
eosinophil-CD8+ T cell feedback loops play a crucial role in maintaining graft survival in vivo. We
have further demonstrated the translational potential of this discovery and ameliorated graft
rejection by altering eosinophil migration into the lung through intra-tracheal administration of
chemokines. Such data provides proof of principle that mechanistic studies utilizing murine
models offer the possibility for the development of lung-specific protocols for immunosuppression
and tolerance induction. In project #2 we propose to decipher multiple aspects of lung allograft-
specific proinflammatory loops in tolerance induction and maintenance. In aim #1 we plan to
explore the interactions of IFN-γ and IL1-β in lung allograft acceptance and in aim #2 we will focus
on antigen specificity in tolerance induction as well as mechanism/s mediating T cell receptor
instability. In aim #3 we will focus on the role of PD-L1 in maintenance of tolerance. In addition
we will explore the potential for bi-specific antibody-mediated induction of tolerance through
forced interaction of eosinophils and T cells. The studies proposed here would lay the foundation
for translational large animal and human work in lung allograft management in an effort to improve
survival.
项目总结/摘要
利用小鼠肺移植模型的研究有助于推进我们的理解
同种异体肺移植物特异性免疫调节。与其他实体器官不同,肺依赖于亲-
炎症反馈回路,用于建立和维持移植物接受性。我们有
描述了CD 8 + T细胞,长期以来被认为对实体器官移植物的存活有害,
在肺移植耐受中的关键作用。在上一次融资期间,我们发现,
肺内嗜酸性粒细胞也被认为是对移植物健康有害的细胞群,
CD 8 + T细胞的命运,以防止其效应分化。我们还描述了这样的情况
嗜酸性粒细胞-CD 8 + T细胞反馈环在维持体内移植物存活中起关键作用。我们
进一步证明了这一发现的转化潜力,
通过气管内给药改变嗜酸性粒细胞向肺内迁移的排斥反应
趋化因子这样的数据提供了利用小鼠的机制研究
模型为肺特异性免疫抑制方案的开发提供了可能性
和耐受诱导。在项目#2中,我们建议破译肺移植的多个方面-
特异性促炎环在耐受诱导和维持中的作用。在目标#1中,我们计划
探讨IFN-γ和IL-1-β在肺移植物接受中的相互作用,在目标2中,我们将重点关注
免疫耐受诱导中的抗原特异性以及介导T细胞受体的机制
不稳定在目标3中,我们将重点关注PD-L1在维持耐受性中的作用。此外
我们将探索双特异性抗体介导的耐受诱导的潜力,
嗜酸性粒细胞和T细胞的强制相互作用。这里提出的研究将奠定基础
用于大型动物和人类肺移植管理的转化工作,以努力改善
生存
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALEXANDER S. KRUPNICK其他文献
ALEXANDER S. KRUPNICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALEXANDER S. KRUPNICK', 18)}}的其他基金
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance
建立和维持肺同种异体移植耐受的炎症细胞机制
- 批准号:
10024445 - 财政年份:2015
- 资助金额:
$ 47.39万 - 项目类别:
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance
建立和维持肺同种异体移植耐受的炎症细胞机制
- 批准号:
10625537 - 财政年份:2015
- 资助金额:
$ 47.39万 - 项目类别:
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance
建立和维持肺同种异体移植耐受的炎症细胞机制
- 批准号:
10619068 - 财政年份:2015
- 资助金额:
$ 47.39万 - 项目类别:
Mechanisms of Immunosurveillance for Lung Cancer-the Role of CD8+ T Cells in Tumor Tolerance Induction
肺癌免疫监视机制——CD8 T细胞在肿瘤耐受诱导中的作用
- 批准号:
10512744 - 财政年份:2014
- 资助金额:
$ 47.39万 - 项目类别:
Mechanisms of Immunosurveillance for Lung Cancer-the Role of CD8+ T Cells in Tumor Tolerance Induction
肺癌免疫监视机制——CD8 T细胞在肿瘤耐受诱导中的作用
- 批准号:
10255913 - 财政年份:2014
- 资助金额:
$ 47.39万 - 项目类别:
相似海外基金
Targeting innate immunity for induction of robust renal allograft tolerance
针对先天免疫诱导强大的肾同种异体移植耐受
- 批准号:
10622050 - 财政年份:2023
- 资助金额:
$ 47.39万 - 项目类别:
Novel Approaches to Inducing Lung Allograft Tolerance in NHPs
诱导 NHP 肺同种异体移植耐受的新方法
- 批准号:
10622123 - 财政年份:2023
- 资助金额:
$ 47.39万 - 项目类别:
Project 1: Next Generation Mixed Chimerism Strategies to Induce Lung Allograft Tolerance in NHPs
项目 1:诱导 NHP 肺同种异体移植耐受的下一代混合嵌合策略
- 批准号:
10622127 - 财政年份:2023
- 资助金额:
$ 47.39万 - 项目类别:
Bcl-2 and Mcl-1 inhibition for induction of hematopoietic chimerism and renal allograft tolerance without myelosuppression in nonhuman primates
在非人灵长类动物中抑制 Bcl-2 和 Mcl-1 可诱导造血嵌合和肾同种异体移植耐受,而无需骨髓抑制
- 批准号:
10634698 - 财政年份:2022
- 资助金额:
$ 47.39万 - 项目类别:
Project 3: Enhanced Costimulation Blockade to Achieve Clinically Relevant Heart Allograft Tolerance
项目 3:增强共刺激阻断以实现临床相关的同种异体移植心脏耐受性
- 批准号:
10457402 - 财政年份:2021
- 资助金额:
$ 47.39万 - 项目类别:
New Approaches to Inducing Cardiac Allograft Tolerance
诱导心脏同种异体移植耐受的新方法
- 批准号:
10673071 - 财政年份:2021
- 资助金额:
$ 47.39万 - 项目类别:
New Approaches to Inducing Cardiac Allograft Tolerance
诱导心脏同种异体移植耐受的新方法
- 批准号:
10457397 - 财政年份:2021
- 资助金额:
$ 47.39万 - 项目类别:
New Approaches to Inducing Cardiac Allograft Tolerance
诱导心脏同种异体移植耐受的新方法
- 批准号:
10270357 - 财政年份:2021
- 资助金额:
$ 47.39万 - 项目类别:
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
项目 2:用于心脏同种异体移植耐受的下一代混合嵌合诱导
- 批准号:
10270361 - 财政年份:2021
- 资助金额:
$ 47.39万 - 项目类别:
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
项目 2:用于心脏同种异体移植耐受的下一代混合嵌合诱导
- 批准号:
10457401 - 财政年份:2021
- 资助金额:
$ 47.39万 - 项目类别:














{{item.name}}会员




